Loyal
United States
- Dallas, TX
- 12/02/2026
- Series C
- $100,000,000
Loyal Animal Health, Inc. is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives.
We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025.
Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to help dogs everywhere.
- Industry Biotechnology Research
- Website https://loyal.com/
- LinkedIn https://www.linkedin.com/company/loyalfordogs/about/
Related People
Celine HaliouaFounder
United States -
San Francisco, California
Interested in: the biology of aging, the impact of healthcare inequality, economics of novel therapeutics, early-stage biotech venture capital. www.celinehh.com
Simple AI | $14,000,000 | (Feb 12, 2026)
Hubbl Technologies | $6,000,000 | (Feb 12, 2026)
Trener Robotics (formerly T-ROBOTICS) | $32,000,000 | (Feb 12, 2026)
Complyance | $20,000,000 | (Feb 12, 2026)
Brandlight | $30,000,000 | (Feb 12, 2026)
Tenna Systems | $13,500,000 | (Feb 12, 2026)
GitGuardian | $50,000,000 | (Feb 12, 2026)
Inertia | $450,000,000 | (Feb 12, 2026)
Birch Hill Holdings | $2,500,000 | (Feb 12, 2026)
Smart Bricks | $5,000,000 | (Feb 12, 2026)
Scala | $8,500,000 | (Feb 12, 2026)